JPRN-UMIN000020626已完成未知
Prospective study of Ombitasvir/Paritaprevir/Ritonavir for HCV genotype 1 intected Japanese patients including patients with chronic kidney disease - IFN free OPR study
Osaka City University and affiliated hospital0 个研究点目标入组 200 人开始时间: 2016年1月19日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Pregnant woman Decompensated cirrhosis hepatocellular carcinoma Doctors judge as inappropriate
研究者
相似试验
已完成
不适用
Efficacy and safety of Ombitasvir/Paritaprevir/Ritonavir in chronic hepatitis C patientsChronic hepatitis CJPRN-UMIN000021123shonan kamakura general hospital100
招募中
不适用
Efficacy and safety of ombitasvir/paritaprevir/ritonavir, ledipasvir/sofosbuvir, elbasvir /grazoprevir, glecaprevir/pibrentasvir after curative treatment of HCV-Related HCC - Prospective multicenter-cooperative cohort studyHCV-related hepatocellular carcinomaJPRN-UMIN000025085Juntendo University Hospital80
招募中
不适用
Evaluation of the efficacy of ombitasvir and paritaprevir with ritonavir for Japanese hepatitis C patients: a prospective study in real-life settings.chronic hepatitis CJPRN-UMIN000021276Toranomon Hospital100
尚未招募
不适用
Efficacy and safety of paritaprevir and ombitasvir in patients with chronic hepatitis CJPRN-UMIN000020019Osaka University Graduate School of Medicine, Department of Gastroenterology and Hepatology2,000
未知
不适用
The efficacy of paritaprevir and ombitasvir with a booster dose of ritonavir in genotype 1 HCV patients with hemodialysishemodialysis patients chronically infected with genotype 1 hepatitis C virusJPRN-UMIN000022563Mitsui Memorial Hospital30